Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1991-04-18
1992-04-07
Nutter, Nathan M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514549, 514558, 514560, 514693, 514705, 514874, A01N 3700, A61K 3120
Patent
active
051029120
ABSTRACT:
This invention describes the use of a hydroxyoctadecadienic acid, its acid oxidized to keto form or the ester derivatives of the acids, where the ester derivatives are low esters with 1 to 4 carbon atoms for the preparation of a pharmaceutical for treatment of breast carcinomas or benign prostatic hyperplasia. In particular, those compounds are suitable in which the double bonds and the hydroxy group or the oxo group are present on the carbon atoms at positions 9 to 13.
REFERENCES:
patent: 4724234 (1988-02-01), Cone, Jr.
patent: 4950688 (1990-08-01), Bowser et al.
Kanoldt Arzneimittel GmbH
Nutter Nathan M.
LandOfFree
Hydroxyoctadecadienic acid for the treatment of estrogen-depende does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydroxyoctadecadienic acid for the treatment of estrogen-depende, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxyoctadecadienic acid for the treatment of estrogen-depende will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1895741